Expertise in
14
conditions

Dr. Andrew C. Wang

Dermatology
1208B VFW Parkway, 
West Roxbury, MA 
Accepting New Patients
17 Years of Experience
Referral may be required
Before you request
Expertise in
14
conditions
1208B VFW Parkway, 
West Roxbury, MA 

Overview

Andrew Wang is a Dermatologist practicing medicine in West Roxbury, Massachusetts. He has been practicing medicine for over 17 years.

Dr. Wang is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Giant Congenital Nevus, Giant Congenital Melanocytic Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, Aortic Valve Replacement, and Pacemaker Implantation.

Dr. Wang is board certified in American Board Of Dermatology. He is actively involved in clinical research, co-authoring 139 peer reviewed articles and participating in 6 clinical trials. Dr. Wang is currently accepting new patients.

Graduate Year

2009

Specialties

Dermatology

Licenses

Internal Medicine in MA

Board Certifications

American Board Of Dermatology

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
MVP Health
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Senior Whole Health
  • MEDICARE-MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

NEDA Brookline LLC
1208B VFW Parkway, West Roxbury, MA 02132

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

PACER (Pancreatic AdenoCarcinoma With Electron Intraoperative Radiation Therapy): A Phase II Study of Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement
PACER (Pancreatic AdenoCarcinoma With Electron Intraoperative Radiation Therapy): A Phase II Study of Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement
Enrollment Status: Active_not_recruiting
Publish Date: July 14, 2026
Intervention Type: Radiation
Study Phase: Not Applicable
An Open-Label Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in Study MYK-461-004 (PIONEER)
An Open-Label Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in Study MYK-461-004 (PIONEER)
Enrollment Status: Completed
Publish Date: January 09, 2025
Intervention Type: Drug
Study Drug: Mavacamten
Study Phase: Phase 2
LCCC 1612: P53 Mutational Status and Circulating Free HPV DNA for the Management of HPV-associated Oropharyngeal Squamous Cell Cancers
LCCC 1612: P53 Mutational Status and Circulating Free HPV DNA for the Management of HPV-associated Oropharyngeal Squamous Cell Cancers
Enrollment Status: Completed
Publish Date: May 02, 2024
Intervention Type: Procedure, Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Concentration-guided, Exploratory Study of Mavacameten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction
A Randomized, Double-blind, Placebo-controlled, Concentration-guided, Exploratory Study of Mavacameten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction
Enrollment Status: Completed
Publish Date: August 09, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Open-label Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
A Phase 2 Open-label Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

139 Total Publications

Defining Meaningful Treatment Responses in Hypertrophic Cardiomyopathy: Seeking a Trifecta Across Phenotypes.
Defining Meaningful Treatment Responses in Hypertrophic Cardiomyopathy: Seeking a Trifecta Across Phenotypes.
Journal: Circulation
Published: August 28, 2026
Similar Doctors
Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required
Before you request

Brigham And Women's Hospital

221 Longwood Ave, 
Boston, MA 
 (5.3 miles away)
617-732-4918
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Merola is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Merola is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Psoriasis, Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), and Plaque Psoriasis. Dr. Merola is currently accepting new patients.

Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required

Brigham Dermatology Associates

221 Longwood Avenue 1st Floor Brigham And Women's At 221 Longwood Boston, 1st Floor Brigham And Women's At 221 Longwood, 
Boston, MA 
 (5.2 miles away)
617-732-4918
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arash Mostaghimi is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Mostaghimi is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Alopecia Areata, Autosomal Recessive Hypotrichosis, Pyoderma Gangrenosum, and Cellulitis. Dr. Mostaghimi is board certified in Dermatology, Clinical Informatics, and Internal Medicine.

Expertise in
25
conditions
Expertise in
25
conditions
Referral required
Before you request

Brigham Dermatology Associates At Brigham And Womens Hospital

221 Longwood Avenue, 
Boston, MA 
 (5.3 miles away)
617-732-4918
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ruth Vleugels is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Vleugels is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Eosinophilic Fasciitis, Cutaneous Lupus Erythematosus (CLE), and Discoid Lupus Erythematosus (DLE). Dr. Vleugels is board certified in Dermatology, 2008. Dr. Vleugels is currently accepting new patients.

Frequently Asked Questions about Dr. Andrew C. Wang

How do I make an appointment with Dr. Andrew C. Wang?

You can book an appointment with Dr. Andrew C. Wang by calling their office at 617-608-1575. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrew C. Wang a top-rated expert for Giant Congenital Nevus?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew C. Wang is classified as an Advanced expert for Giant Congenital Nevus, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrew C. Wang specialize in?

While Dr. Andrew C. Wang is a Dermatology, they have specific expertise in Giant Congenital Nevus, Giant Congenital Melanocytic Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Andrew C. Wang participate in research or clinical trials?

Yes. Dr. Andrew C. Wang has published 139 articles and abstracts on conditions like Giant Congenital Nevus. You can view a list of Dr. Andrew C. Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andrew C. Wang accept my insurance?

Dr. Andrew C. Wang accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-608-1575 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wang's expertise for a condition
ConditionClose
      View All 14 Advanced Conditions
      View All 50 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile